首页 | 本学科首页   官方微博 | 高级检索  
检索        

度洛西汀和阿米替林对抑郁症患者生命质量的影响
引用本文:王继辉,吴小立,魏钦令,韩自力.度洛西汀和阿米替林对抑郁症患者生命质量的影响[J].中国临床药理学与治疗学,2011,16(1):67-71.
作者姓名:王继辉  吴小立  魏钦令  韩自力
作者单位:中山大学附属第三医院心理科,广州,510630,广东
基金项目:2009广东省自然科学基金(9151008901000065)
摘    要:目的:研究度洛西汀和阿米替林对抑郁症患者生命质量的影响,以及生命质量和疗效及药物副作用的相关性。方法:将57例抑郁症患者随机分为度洛西汀组(研究组,30例)和阿米替林组(对照组,27例),疗程6周。在基线和1、2、4、6周后,给予评定健康状况问卷(SF-36)、汉密尔顿抑郁量表(HAMD)(24项版)、汉密尔顿焦虑量表(HAMA)、治疗过程出现症状量表(TESS)。结果:治疗6周后,研究组和对照组有效率相近,分别为86.67%(26/30)、85.19%(23/27),P>0.05;痊愈率相近,分别为46.67%(14/30)、44.44%(12/27),P>0.05;对照组不良反应发生率高于研究组(77.78%vs36.67%,P<0.05);治疗6周后,研究组SF-36各因子分均高于对照组(P<0.05)。SF-36多项因子分的提高和HAMD减分率、HAMA减分率成正相关,和TESS总分成负相关(P<0.05)。结论:度洛西汀对抑郁症患者生命质量的改善优于阿米替林;抑郁症患者生命质量和焦虑、抑郁情绪的改善及药物治疗的副作用密切相关。

关 键 词:抑郁症  生命质量  度洛西汀  阿米替林

A comparative study of efficacy on the quality of life between duloxetine and amitriptyline in treating patients with depression
WANG Ji-hui,WU Xiao-li,WEI Qin-ling,HAN Zi-li.A comparative study of efficacy on the quality of life between duloxetine and amitriptyline in treating patients with depression[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2011,16(1):67-71.
Authors:WANG Ji-hui  WU Xiao-li  WEI Qin-ling  HAN Zi-li
Institution:WANG Ji-hui,WU Xiao-li,WEI Qin-ling,HAN Zi-li Department of Psychology,3rd Affiliated Hospital,Sun Yat-sen University,Guangzhou 510630,Guangdong,China
Abstract:AIM : To study the efficacy on the quality of life between duloxetine and amitriptyline in treating patients with depression. METHODS : 57 patients were randomized to either duloxetine group(research group,n =30) or amitriptyline group(control group,n =27) for a 6-week period treatment.All patients were assessed with Short-Form-36 Health Survey(SF-36),Hamilton Depression Scale(HAMD,24-items),Hamilton Anxiety Scale(HAMA) and the Treatment Emergent Symptom Scale(TESS) before treatment and at the ends of the 1...
Keywords:Depression  Quality of life  Duloxetine  Amitriptyline  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号